Nano-Medicine for Thrombosis: A Precise Diagnosis and Treatment Strategy

Overview

Journal Nanomicro Lett

Publisher Springer

Date 2021 Jun 17

PMID 34138079

Citations 28

Authors

Min Su

Qixuan Dai

Chuan Chen

Yun Zeng

Chengchao Chu

Gang Liu

Affiliations

Soon will be listed here.

Abstract

Thrombosis is a global health issue and one of the leading factors of death. However, its diagnosis has been limited to the late stages, and its therapeutic window is too narrow to provide reasonable and effective treatment. In addition, clinical thrombolytics suffer from a short half-life, allergic reactions, inactivation, and unwanted tissue hemorrhage. Nano-medicines have gained extensive attention in diagnosis, drug delivery, and photo/sound/magnetic-theranostics due to their convertible properties. Furthermore, diagnosis and treatment of thrombosis using nano-medicines have also been widely studied. This review summarizes the recent advances in this area, which revealed six types of nanoparticle approaches: (1) in vitro diagnostic kits using "synthetic biomarkers"; (2) in vivo imaging using nano-contrast agents; (3) targeted drug delivery systems using artificial nanoparticles; (4) microenvironment responsive drug delivery systems; (5) drug delivery systems using biological nanostructures; and (6) treatments with external irradiation. The investigations of nano-medicines are believed to be of great significance, and some of the advanced drug delivery systems show potential applications in clinical theranotics.

Citing Articles

Enhancing the Efficacy of Active Pharmaceutical Ingredients in Medicinal Plants through Nanoformulations: A Promising Field.

Chen Y, Tang Y, Li Y, Rui Y, Zhang P Nanomaterials (Basel). 2024; 14(19).

PMID: 39404324 PMC: 11478102. DOI: 10.3390/nano14191598.

Aggregation-Induced Emission Luminogen: Role in Biopsy for Precision Medicine.

Duo Y, Han L, Yang Y, Wang Z, Wang L, Chen J Chem Rev. 2024; 124(20):11242-11347.

PMID: 39380213 PMC: 11503637. DOI: 10.1021/acs.chemrev.4c00244.

Emerging Perspectives on Prime Editor Delivery to the Brain.

BenDavid E, Ramezanian S, Lu Y, Rousseau J, Schroeder A, Lavertu M Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931430 PMC: 11206523. DOI: 10.3390/ph17060763.

pH-Responsive Theranostic Colloidosome Drug Carriers Enable Real-Time Imaging of Targeted Thrombolytic Process with Near-Infrared-II for Deep Venous Thrombosis.

Ye Y, Chen Z, Zhang S, Slezak P, Lu F, Xie R Research (Wash D C). 2024; 7:0388.

PMID: 38812529 PMC: 11136571. DOI: 10.34133/research.0388.

Role of the gut microbiota in tumorigenesis and treatment.

Liu Q, Yang Y, Pan M, Yang F, Yu Y, Qian Z Theranostics. 2024; 14(6):2304-2328.

PMID: 38646653 PMC: 11024857. DOI: 10.7150/thno.91700.

References

Jinatongthai P, Kongwatcharapong J, Foo C, Phrommintikul A, Nathisuwan S, Thakkinstian A . Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis. Lancet. 2017; 390(10096):747-759. DOI: 10.1016/S0140-6736(17)31441-1. View

Lux J, Vezeridis A, Hoyt K, Adams S, Armstrong A, Sirsi S . Thrombin-Activatable Microbubbles as Potential Ultrasound Contrast Agents for the Detection of Acute Thrombosis. ACS Appl Mater Interfaces. 2017; 9(43):37587-37596. PMC: 5691601. DOI: 10.1021/acsami.7b10592. View

Vymazal J, Spuentrup E, Cardenas-Molina G, Wiethoff A, Hartmann M, Caravan P . Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility. Invest Radiol. 2009; 44(11):697-704. DOI: 10.1097/RLI.0b013e3181b092a7. View

Li J, Rao J, Pu K . Recent progress on semiconducting polymer nanoparticles for molecular imaging and cancer phototherapy. Biomaterials. 2017; 155:217-235. PMC: 5978728. DOI: 10.1016/j.biomaterials.2017.11.025. View

Min Y, Caster J, Eblan M, Wang A . Clinical Translation of Nanomedicine. Chem Rev. 2015; 115(19):11147-90. PMC: 4607605. DOI: 10.1021/acs.chemrev.5b00116. View

Liu Y, Bhattarai P, Dai Z, Chen X . Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem Soc Rev. 2018; 48(7):2053-2108. PMC: 6437026. DOI: 10.1039/c8cs00618k. View

Schwartz R, Burke A, Farb A, Kaye D, Lesser J, Henry T . Microemboli and microvascular obstruction in acute coronary thrombosis and sudden coronary death: relation to epicardial plaque histopathology. J Am Coll Cardiol. 2009; 54(23):2167-73. DOI: 10.1016/j.jacc.2009.07.042. View

Go A, Mozaffarian D, Roger V, Benjamin E, Berry J, Blaha M . Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014; 129(3):399-410. DOI: 10.1161/01.cir.0000442015.53336.12. View

Nakatsuka M, Mattrey R, Esener S, Cha J, Goodwin A . Aptamer-crosslinked microbubbles: smart contrast agents for thrombin-activated ultrasound imaging. Adv Mater. 2012; 24(45):6010-6. PMC: 3626403. DOI: 10.1002/adma.201201484. View

10.

Hu Q, Qian C, Sun W, Wang J, Chen Z, Bomba H . Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus. Adv Mater. 2016; 28(43):9573-9580. PMC: 5283718. DOI: 10.1002/adma.201603463. View

11.

Gunawan S, Kempe K, Bonnard T, Cui J, Alt K, Law L . Multifunctional Thrombin-Activatable Polymer Capsules for Specific Targeting to Activated Platelets. Adv Mater. 2015; 27(35):5153-7. DOI: 10.1002/adma.201502243. View

12.

Cui C, Yang Z, Hu X, Wu J, Shou K, Ma H . Organic Semiconducting Nanoparticles as Efficient Photoacoustic Agents for Lightening Early Thrombus and Monitoring Thrombolysis in Living Mice. ACS Nano. 2017; 11(3):3298-3310. DOI: 10.1021/acsnano.7b00594. View

13.

Li S, Cheng H, Xie B, Qiu W, Zeng J, Li C . Cancer Cell Membrane Camouflaged Cascade Bioreactor for Cancer Targeted Starvation and Photodynamic Therapy. ACS Nano. 2017; 11(7):7006-7018. DOI: 10.1021/acsnano.7b02533. View

14.

Liang C, Xu L, Song G, Liu Z . Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy. Chem Soc Rev. 2016; 45(22):6250-6269. DOI: 10.1039/c6cs00458j. View

15.

Xu L, Mou F, Gong H, Luo M, Guan J . Light-driven micro/nanomotors: from fundamentals to applications. Chem Soc Rev. 2017; 46(22):6905-6926. DOI: 10.1039/c7cs00516d. View

16.

Hill B, Zak A, Khera E, Wen F . Engineering Virus-like Particles for Antigen and Drug Delivery. Curr Protein Pept Sci. 2016; 19(1):112-127. DOI: 10.2174/1389203718666161122113041. View

17.

Miao W, Kim H, Gujrati V, Kim J, Jon H, Lee Y . Photo-decomposable Organic Nanoparticles for Combined Tumor Optical Imaging and Multiple Phototherapies. Theranostics. 2016; 6(13):2367-2379. PMC: 5118601. DOI: 10.7150/thno.15829. View

18.

Sun T, Zhang Y, Pang B, Hyun D, Yang M, Xia Y . Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed Engl. 2014; 53(46):12320-64. DOI: 10.1002/anie.201403036. View

19.

Gorog D, Fayad Z, Fuster V . Arterial Thrombus Stability: Does It Matter and Can We Detect It?. J Am Coll Cardiol. 2017; 70(16):2036-2047. DOI: 10.1016/j.jacc.2017.08.065. View

20.

Ashton J, Castle K, Qi Y, Kirsch D, West J, Badea C . Dual-Energy CT Imaging of Tumor Liposome Delivery After Gold Nanoparticle-Augmented Radiation Therapy. Theranostics. 2018; 8(7):1782-1797. PMC: 5858500. DOI: 10.7150/thno.22621. View